Literature DB >> 2498468

Promising new drugs in the treatment of tuberculosis and mycobacteriosis.

M Casal1, F Rodríguez, J Gutierrez, P Ruiz, M C Benavente, R Villalba, G Moreno.   

Abstract

The aims of this work were to investigate the possible effect of several antimicrobial agents alone and in combinations against 190 clinical isolates of Mycobacterium tuberculosis and 30 isolates of Mycobacterium avium, 30 Mycobacterium fortuitum and 30 Mycobacterium chelonei. The susceptibility was determined in Müller-Hinton agar and Middlebrook 7H 10 agar. For interpretation of the results the minimum inhibitory concentration (MIC) was determined and for the combinations of antimicrobials we used the Fractional Inhibitory Concentration Index (FIC). The possible clinical efficacy was determined by the Inhibitory Quotient. The synergistic effect of several combinations of these compounds was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498468     DOI: 10.1080/1120009x.1989.11738862

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  3 in total

1.  Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid.

Authors:  R J Wallace; B A Brown; G O Onyi
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

2.  Beta-lactamase of Mycobacterium fortuitum: kinetics of production and relationship with resistance to beta-lactam antibiotics.

Authors:  L Fattorini; G Scardaci; S H Jin; G Amicosante; N Franceschini; A Oratore; G Orefici
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

3.  In vitro activity of roxithromycin against the Mycobacterium tuberculosis complex.

Authors:  N Rastogi; K S Goh; P Ruiz; M Casal
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.